BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2012
View Archived Issues
Novel GlyT1 inhibitors developed
Read More
Canadian study assesses involvement of neuroinflammation in healthy aging humans
Read More
Agenus and GSK expand license agreement for vaccine adjuvant
Read More
FDA clears IND application for phase III trial of melanoma vaccine
Read More
Phase III SAR-1118 trial completes enrollment
Read More
Palatin Technologies completes enrollment in phase IIb bremelanotide trial
Read More
Bayer HealthCare obtains new product approval
Read More
Isis launches phase I trial of first-generation antisense drug
Read More
Novel candidate schizophrenia therapies patented by Takeda
Read More
RaQualia Pharma presents novel sodium channel antagonists
Read More
Roche develops new inhibitors of tyrosine-protein kinase BTK
Read More
Novel phosphodiesterase 9A inhibitors reported
Read More
Celgene completes acquisition
Read More
NeuroTherapeutics Pharma divulges new GABA(A) receptor antagonists
Read More
Researchers in U.S. design new therapeutics for radiation injury
Read More
Benitec Biopharma enters into new licensing agreement
Read More
University of Dundee and GSK to target neglected parasitic diseases
Read More
Apexigen grants license for APX-004 development in China
Read More
Viral Genetics submits pre-IND for Lyme disease treatment
Read More
Gene-modified stem cell therapy shows promise to combat HIV infection
Read More
Study of AEZS-130 in cancer cachexia begins
Read More
Thrombotech clear to test THR-18 in U.S.
Read More
Apogenix's phase II trial in glioblastoma multiforme meets primary endpoint
Read More
Repligen submits MAA for SecreFlo
Read More
Recombinant protein therapy active against HIV in phase II trial
Read More